TRiBECA® Knowledge @KnowledgePharma

We're a unique tech innovator that specialises in Launch Readiness, Market Access and Tender Management software for #Pharma , #Biotech and #Healthcare info.tribecaknowledge.com/pharma-launch-… London Joined June 2011

Tweets

1K
Followers

286
Following

781
Likes

15

TRiBECA® Knowledge @KnowledgePharma

2 years ago

Market Access 2023: New Report on key challenges in HTA and reimbursement - As market access barriers proliferate, digitally enabled alignment is key to optimising new drug uptake. bit.ly/3olM5sO

0 0 0 42 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

Launch Readiness 2023: Key trends impacting pharma product launches bit.ly/40KAwdu

0 0 1 38 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

How can industry embrace prevention without undermining its core focus on treatment innovation? #launchinnovation bit.ly/3ZiCNvY

0 0 0 38 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

What makes the Clarity AD results with Eisai/Biogen’s #lecanemab in early Alzheimer’s so important? bit.ly/3vEtsRe

0 0 0 82 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

How does the EU regulation reflect a broader shift towards more harmonised #HTA procedures? bit.ly/3vEtBnK

0 0 0 26 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

What can companies do to ensure #launchexcellence in the difficult post-COVID environment? bit.ly/3vBpdWE

0 0 0 15 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

Which provisions in the #InflationReductionAct could particularly hurt pharma? bit.ly/3Qa3cYq

0 0 0 19 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

Why should the pharmaceutical industry get more involved in #diseaseprevention?bit.ly/3GCONkG

0 0 0 10 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

What is the current prognosis for treating #Alzheimers and other age-related diseases?bit.ly/3i7eMag

0 0 0 13 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

Is the EU’s new regulation on health technology assessment a platform for #HTA harmonisation?bit.ly/3GCON4a

0 0 0 12 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

What does the #USInflationReductionAct mean for the pharmaceutical industry?bit.ly/3vAgDaQ

0 0 0 7 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

What is the long-term impact of COViD-19 on #pharmalaunches and market access?bit.ly/3Q7QZDT

0 0 0 11 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

What is the five-year trend for #FDA and #EMA drug approvals? bit.ly/3Z4HKYZ

0 0 0 11 0

TRiBECA® Knowledge @KnowledgePharma

3 years ago

5 Pharma Trends for 2023: Challenges and opportunities in the post-COVID landscape bit.ly/3VZZUsv

0 0 0 0 0

TRiBECA® Knowledge @KnowledgePharma

4 years ago

Do you have the right tools to convert drug approvals into launch excellence? bit.ly/34f8EWr

0 0 0 0 0

TRiBECA® Knowledge @KnowledgePharma

4 years ago

What are the drivers of post-pandemic launch excellence in #pharma? bit.ly/3ASOflW

0 0 0 0 0

TRiBECA® Knowledge @KnowledgePharma

4 years ago

"Although I most often found myself in a male-dominated sector, banking then government then pharma, the gender mix was never a deterrent." - Sherry Moran . . #IWD2022 #InternationalWomensDay #InternationWomensDay2022 #InspiringWomen #WomenLeaders #BreakTheBias #Equality